We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Single Agent Paclitaxel as a First-line Therapy in Advanced Urothelial Carcinoma: Its Efficacy and Safety in Patients Even With Pretreatment Renal Insufficiency.
- Authors
Yang, Muh-Hwa; Muh-Hwa Yang; Yen, Chueh-Chuan; Chueh-Chan Yen; Chang, Yen-Hwa; Yen-Hwa Chang; Hsieh, Ruey-Kuen; Ruey-Kuen Hsieh; Liu, Jin-Hwang; Jin-Hwang Liu; Chiou, Tzeon-Jye; Tzeon-Jye Chiou; Fan, Frank S.; Lin, Alex Ton-Ling; Huang, William Ji-Shien; Wang, Wei-Shu; Wei-Shu Wang; Chen, Kuang-Kuo; Kuang-Kuo Chen; Chen, Po-Min
- Abstract
Evaluates the efficacy and safety of paclitaxel as a first-line therapy in advanced urothelial carcinoma patients. Major toxicities of cisplatin-based chemotherapy; Comparison of the response and survival rate between patients with normal renal function and those with renal insufficiency.
- Subjects
PACLITAXEL; BLADDER cancer; CISPLATIN; DRUG therapy; DRUG efficacy; TOXICOLOGY
- Publication
Japanese Journal of Clinical Oncology, 2000, Vol 30, Issue 12, p547
- ISSN
0368-2811
- Publication type
Article
- DOI
10.1093/jjco/hyd142